Certified Advisory Corp’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-17
Closed -$3K 836
2020
Q1
$3K Hold
17
﹤0.01% 679
2019
Q4
$3K Hold
17
﹤0.01% 719
2019
Q3
$3K Hold
17
﹤0.01% 722
2019
Q2
$3K Hold
17
﹤0.01% 736
2019
Q1
$2K Buy
17
+1
+6% +$145 ﹤0.01% 707
2018
Q4
$2K Hold
16
﹤0.01% 701
2018
Q3
$3K Hold
16
﹤0.01% 704
2018
Q2
$3K Hold
16
﹤0.01% 687
2018
Q1
$2K Hold
16
﹤0.01% 684
2017
Q4
$2K Buy
+16
New +$2.87K ﹤0.01% 654

Other funds holding AGN

Certified Advisory Corp's AGN Position: Q2 2020 in Review

Certified Advisory Corp sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 17 shares — an estimated $3K sold.

Certified Advisory Corp first reported a position in AGN in Q4 2017 and held it in 10 quarters. The position peaked at $3K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Certified Advisory Corp reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Certified Advisory Corp sold 17 Allergan plc shares in Q2 2020, an estimated $3K.
  • Certified Advisory Corp first reported a position in Allergan plc in Q4 2017 and held it in 10 quarters.
  • Certified Advisory Corp's Allergan plc position peaked at $3K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Certified Advisory Corp's 13F filing for Q2 2020, filed 27 Jul 2020.